The venture capital company Ysios Capital, a member of CATALONIA.HEALTH, has announced that its investee company, ReproNovo has closed a $65 milions Series A financing round.

The pharmaceutical company Reig Jofre, a member of CATALONIA.HEALTH, has been selected to receive a €13 million grant from the Centre for the Development of Industrial Technology (CDTI). 

The neurotechnology company INBRAIN Neuroelectronics, a member of CATALONIA.HEALTH, has received a 4 million euros’ grant from the Spanish Ministry of Industry and Tourism through the PERTE Chip initiative, a national programme to support the most revolutionary innovation in microelectronics, semiconductors and deeptech.

The public-private consortium formed by the biopharmaceutical company Oniria Therapeutics, a member of CATALONIA.HEALTH, the Spanish National Research Council (CSIC) and the Vall d'Hebron Institute of Oncology (VHIO) has obtained 2 million euros of funding from the Ministry of Science, Innovation and Universities of Spain and the European Union, through the Public-Private Collaboration Program 2023. 

CATALONIA.HEALTH incorpora a Arantxa Sanz com a directora general de l’entitat. Amb aquest nou lideratge, s’inicia una nova etapa enfocada a consolidar el seu posicionament dins l’ecosistema i a reforçar les aliances entre el món científic, empresarial i institucional.

The medical diagnostics company Deepull, a member of CATALONIA.HEALTH, has announced the closing of a €50 million Series C financing round. 

New studies emphasize how peptide-based launches, the core of the Gate2Brain technological platform, a member of CATALONIA.HEALTH, are poised to revolutionise drug administration through the blood-brain barrier. 

Why are biotechs booming in Barcelona? Nature, the most prestigious scientific journal in the world, has highlighted three biotech startups based in Barcelona and members of CATALONIA.HEALTH, Nuage Therapeutics, Ona Therapeutics and SpliceBio.

The Board of Trustees of the Josep Carreras Leukaemia Research Institute, a member of CATALONIA.HEALTH, has approved the appointment of Ari Melnick as the new Director of the centre.

The R&D pharma company Accure Therapeutics, a member of CATALONIA.HEALTH, has received two grants totalling 1.6 million of dollars, $1.12M in grants awarded by The Michael J. Fox Foundation (MJFF) and $0.48M by the Luxembourg National Research Fund (FNR) for two separate development programs on its drug candidate ACT-02.